ProfOsama Soliman

"Developing the world's first AI-powered Cardiovascular Digital Twin to revolutionize precision medicine and save lives through personalized treatment.

Professor Osama Soliman pioneers precision cardiovascular medicine by integrating advanced imaging, artificial intelligence, and digital twin technology to transform how we predict, prevent, and treat heart disease. His work bridges the gap between cutting-edge research and clinical application, translating complex data into personalized patient care strategies. As Deputy Director of CVRI Dublin and Professor at RCSI, he leads €10+ million in active research programs developing next-generation cardiovascular therapies.

With 27 years of clinical and academic excellence, Professor Soliman has authored 400+ peer-reviewed publications (H-index: 55, 11,000+ citations) and established world-class imaging Core Labs across three countries. He designed and leads landmark international registries including EuroEchoVAD, UCARE, and the INCEPTION cardio-oncology studies. His innovations have directly influenced clinical practice guidelines and device development for Abbott, Boston Scientific, and Medtronic.

Professor Soliman currently directs the Precision Cardiovascular Medicine and Innovation at CVRI Dublin, building the world's first comprehensive cardiovascular digital twin platform. His team combines state-of-the-art imaging, genomics, AI, and continuous monitoring to create personalized treatment pathways for heart failure, structural heart disease, and cancer therapy-related cardiac complications. This work is supported by recent competitive awards including the €2.5M EIC Transition Grant for the HeartWise revolutionary right ventricular assist device and €7.1M DTIF DUO MAX Grant.

Professor Soliman welcomes collaborations with clinicians, researchers, industry partners, and funding bodies interested in advancing precision cardiovascular medicine through innovative imaging, AI applications, and digital health technologies."